Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

Saas, P; Walker, P R; Hahne, M; Quiquerez, A L; Schnuriger, V; Perrin, G; French, L; Van Meir, E G; de Tribolet, N; Tschopp, J; Dietrich, P Y

Saas, P; Walker, P R; Hahne, M; Quiquerez, A L; Schnuriger, V; Perrin, G; French, L; Van Meir, E G; de Tribolet, N; Tschopp, J; Dietrich, P Y.

Affiliation

Saas P; Division of Oncology, University Hospital, Geneva, Switzerland.

J Clin Invest ; 99(6): 1173-8, 1997 Mar 15.

Article in En | MEDLINE | ID: mdl-9077524

Subject(s)

Astrocytoma/immunology; Brain Neoplasms/immunology; Brain/immunology; Membrane Glycoproteins/biosynthesis; fas Receptor/metabolism; Animals; Astrocytoma/metabolism; Astrocytoma/pathology; Brain/metabolism; Brain/pathology; Brain Neoplasms/metabolism; Brain Neoplasms/pathology; Cytotoxicity Tests, Immunologic; Fas Ligand Protein; Humans; Ligands; Membrane Glycoproteins/physiology; Mice; Rats; Tumor Cells, Cultured

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Astrocytoma / Brain / Brain Neoplasms / Membrane Glycoproteins / Fas Receptor Limits: Animals / Humans Language: En Journal: J Clin Invest Year: 1997 Type: Article Affiliation country: Switzerland

Fulltext

XML

PubMed Links

Search on Google